Browse Category

Stock Market News 25 January 2026

Tesla stock braces for earnings week after Tesla puts key Autopilot features behind $99-a-month FSD

Tesla stock braces for earnings week after Tesla puts key Autopilot features behind $99-a-month FSD

Tesla has removed Autosteer and some highway driver-assist features from its standard package in the U.S. and Canada, directing buyers to a $99/month Full Self-Driving subscription. The move comes days before Tesla’s Jan. 28 earnings report, as investors watch software revenue and regulatory scrutiny. Shares closed Friday at $449.06, down 0.1%. California’s DMV has warned Tesla over potentially misleading marketing.
Opendoor stock drops 6% into Fed week — what OPEN shares are up against next

Opendoor stock drops 6% into Fed week — what OPEN shares are up against next

Opendoor shares fell 6.4% to $6.01 Friday, with trading volume jumping to 63.7 million ahead of next week’s Federal Reserve rate decision. The drop came as mortgage rates hovered near three-year lows and peers like Zillow and Rocket also slipped. Opendoor will report fourth-quarter earnings on Feb. 26. Investors are watching for Fed signals and housing data due Jan. 27.
Plug Power stock whipsaws near $2.50 as investors brace for Jan. 29 share vote

Plug Power stock whipsaws near $2.50 as investors brace for Jan. 29 share vote

Plug Power shares fell 3.47% to $2.50 Friday, with volume topping 107.9 million ahead of a Jan. 29 shareholder vote on doubling authorized shares and changing voting rules. The company warned it may pursue a reverse stock split if the proposal fails. Plug also reported completion of a 100 MW electrolyzer installation at Galp’s Sines refinery in Portugal. Walmart canceled a warrant for up to 55.3 million Plug shares earlier this month.
25 January 2026
ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

ImmunityBio shares fell 12.1% to $6.45 Friday after the company previewed new data from its Phase 2 glioblastoma trial, with full results due Jan. 31. The stock traded heavily between $7.88 and $6.43. Median overall survival in the study was “not yet reached” as of Jan. 22, with 19 of 23 patients alive. Investors are watching for more details on durability, safety, and trial design.
Grab (GRAB) stock near $4.6 as GoTo takeover talks hit a snag — what to watch next week

Grab (GRAB) stock near $4.6 as GoTo takeover talks hit a snag — what to watch next week

Grab Holdings shares closed up 0.7% at $4.58 after reports that its planned takeover of GoTo faced new resistance from state-linked shareholder Telkomsel. Talks reportedly stalled over Telkomsel’s 2% stake, with the carrier unwilling to sell at current prices. Antitrust concerns and draft Indonesian regulations add further uncertainty. Grab and GoTo declined to comment.
25 January 2026
Intel stock price tumbles 17% on outlook shock — what to watch before Monday’s open

Intel stock price tumbles 17% on outlook shock — what to watch before Monday’s open

Intel shares fell 17% to $45.07 after the company forecast first-quarter revenue below Wall Street expectations and reported a 4% year-over-year decline in fourth-quarter revenue. The company cited supply constraints in its AI data center chips and warned supply would be tightest in Q1. Nearly 295 million shares traded. CEO Lip-Bu Tan said Intel cannot fully meet demand in the short term.
25 January 2026
BigBear.ai stock set for a fresh test Monday as BBAI slips and a dilution vote hangs over shares

BigBear.ai stock set for a fresh test Monday as BBAI slips and a dilution vote hangs over shares

BigBear.ai shares closed Friday down 1.9% at $5.82, with 86.5 million shares traded. Shareholders will vote Feb. 18 on doubling authorized shares to 1 billion, following full conversion of $125 million in convertible notes and a new CargoSeer technology deal. CEO Kevin McAleenan urged approval, citing limited shares left. Voting ends Feb. 17 at 11:59 p.m. ET.
25 January 2026
Bloom Energy stock price heads into Monday after Friday dip as data centers talk more onsite power

Bloom Energy stock price heads into Monday after Friday dip as data centers talk more onsite power

Bloom Energy shares closed at $144.89 Friday, down 0.5% after a volatile session, but remain up 67% year-to-date. The stock hit a high of $155.87 earlier in the week amid surging interest in onsite power for data centers. Investors await Bloom’s Q4 results on Feb. 5, with focus on data center bookings and margins. Fuel-cell peers showed mixed moves Friday, with Plug Power falling and FuelCell Energy rising.
Vertical Aerospace stock price (EVTL) slips as Valo New York push meets dilution worries

Vertical Aerospace stock price (EVTL) slips as Valo New York push meets dilution worries

Vertical Aerospace shares fell 2.6% to $5.60 Friday, closing out a week down nearly 7%. The company disclosed an expanded authorized share pool to 1 billion, raising dilution concerns as it pursues funding. Vertical is promoting its Valo eVTOL in New York with Bristow and Skyports. Cash on hand stood at about £69 million ($93 million) as of Dec. 31, 2025, according to preliminary filings.
USA Rare Earth stock faces Monday test after report of $1.6 billion U.S. stake deal

USA Rare Earth stock faces Monday test after report of $1.6 billion U.S. stake deal

USA Rare Earth (USAR.O) shares jumped 9.1% to $24.77 Friday after sources said the U.S. will take a 10% stake in a $1.6 billion deal, with an announcement expected Monday. The government is set to receive 16.1 million shares and warrants for 17.6 million more at $17.17 each. Investors await details on financing terms and possible dilution. The White House and company declined comment.
Joby Aviation stock slips 4% before Wall Street reopens — here’s what investors watch next

Joby Aviation stock slips 4% before Wall Street reopens — here’s what investors watch next

Joby Aviation shares fell 4.2% to $13.93 Friday as small-cap stocks slumped, with the Russell 2000 down 1.8%. The drop comes ahead of the Federal Reserve’s Jan. 27-28 meeting and a wave of major earnings reports. Joby’s next earnings report is set for Feb. 25, with investors watching certification progress and cash burn. Joby recently agreed to buy a $61.5 million Ohio property to expand production.
Antofagasta stock faces Monday test after Chile roadblock strike, Centinela fine ahead of Q4 update

Antofagasta stock faces Monday test after Chile roadblock strike, Centinela fine ahead of Q4 update

Antofagasta shares closed up 1.9% at 3,584 pence Friday, despite striking contractors blocking access to the Zaldivar mine in Chile over the weekend. Chile’s regulator fined Antofagasta Minerals about $775,000 for water-management breaches at Centinela. Copper prices rose, with LME cash settlement at $12,920.50 per ton. Antofagasta will release its Q4 production report Jan. 29.
25 January 2026

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
New York, Feb 7, 2026, 17:36 EST — Market closed. Walt Disney shares rose 3.6% on Friday to close at $108.70, trimming the damage from an early-week slide as U.S. stocks snapped back into risk-on mode. (Yahoo Finance) With U.S. markets shut for the weekend, the next session opens with Disney caught between two big forces: a market that is suddenly willing to buy again, and a media business that is still being rewired in public. For Disney, that matters now because its most visible growth levers — streaming and experiences — move on sentiment as much as on the
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop